We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.64B
AUM Growth
+$107M
Cap. Flow
-$27.6M
Cap. Flow %
-1.68%
Top 10 Hldgs %
49.21%
Holding
139
New
8
Increased
12
Reduced
49
Closed
9

Top Buys

Rank Stock Value
1
ROK icon
Rockwell Automation
ROK
+$12M
2
CRM icon
Salesforce
CRM
+$11.5M
3
ADBE icon
Adobe
ADBE
+$11.4M
4
LIN icon
Linde
LIN
+$3.5M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.92M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.3M
2
CTSH icon
Cognizant
CTSH
+$10.2M
3
EBAY icon
eBay
EBAY
+$9.29M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.2M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.01M

Sector Composition

Rank Sector Weight
1 Technology 47.92%
2 Communication Services 14.08%
3 Financials 12.63%
4 Healthcare 11%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
51
Veeva Systems
VEEV
$32.7B
$4.3M 0.26%
14,446
+4,225
+41% +$1.19M
FFIV icon
52
F5
FFIV
$22.9B
$4.27M 0.26%
13,211
ISRG icon
53
Intuitive Surgical
ISRG
$130B
$3.92M 0.24%
8,760
CAH icon
54
Cardinal Health
CAH
$54.5B
$3.84M 0.23%
24,443
CRWD icon
55
CrowdStrike
CRWD
$185B
$3.76M 0.23%
30,704
FLUT icon
56
Flutter Entertainment
FLUT
$18.9B
$3.58M 0.22%
14,102
EXEL icon
57
Exelixis
EXEL
$14.2B
$3.57M 0.22%
86,544
LIN icon
58
Linde
LIN
$236B
$3.51M 0.21%
+7,398
New +$3.5M
COR icon
59
Cencora
COR
$62.2B
$3.34M 0.2%
10,673
DGX icon
60
Quest Diagnostics
DGX
$26B
$3.32M 0.2%
17,442
KLIC icon
61
Kulicke & Soffa
KLIC
$4.76B
$3.32M 0.2%
81,751
+521
+0.6% +$19.3K
SIMO icon
62
Silicon Motion
SIMO
$7.51B
$3.12M 0.19%
32,884
-166
-0.5% -$13.2K
UTHR icon
63
United Therapeutics
UTHR
$26.1B
$3.09M 0.19%
7,365
JAZZ icon
64
Jazz Pharmaceuticals
JAZZ
$16.1B
$2.91M 0.18%
22,095
MELI icon
65
Mercado Libre
MELI
$94.4B
$2.8M 0.17%
1,200
ENSG icon
66
The Ensign Group
ENSG
$10.7B
$2.59M 0.16%
14,976
-110
-0.7% -$17.5K
NEM icon
67
Newmont
NEM
$96.4B
$2.41M 0.15%
28,633
+24,253
+554% +$1.69M
ESAB icon
68
ESAB
ESAB
$5.54B
$2.35M 0.14%
21,079
-75
-0.4% -$8.92K
MEDP icon
69
Medpace
MEDP
$15.9B
$2.3M 0.14%
4,471
YOU icon
70
Clear Secure
YOU
$5.43B
$2.23M 0.14%
66,671
-35
-0.1% -$1.16K
FTNT icon
71
Fortinet
FTNT
$110B
$2.18M 0.13%
25,980
APP icon
72
Applovin
APP
$140B
$2.16M 0.13%
3,000
NTRS icon
73
Northern Trust
NTRS
$22.2B
$2.15M 0.13%
15,940
TMO icon
74
Thermo Fisher Scientific
TMO
$214B
$2M 0.12%
+4,118
New +$1.92M
JNJ icon
75
Johnson & Johnson
JNJ
$643B
$1.94M 0.12%
10,483

Similar funds

Oak Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Oak Associates held 139 positions worth $1.64B, up 7% from $1.53B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Oak Associates's Q3 2025 filing shows 8 new, 12 increased, 49 reduced and 9 closed positions. Its largest new stake was Rockwell Automation: 34,849 shares worth $12.2M. The largest sale was Pfizer, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Communication Services and Financials.

  • Oak Associates's largest Q3 2025 buy was Rockwell Automation: 34,849 shares worth $12.2M.
  • Oak Associates added most to Salesforce in Q3 2025, an estimated $11.5M increase.
  • Oak Associates's biggest Q3 2025 reduction was eBay, cutting an estimated $9.29M.
  • Oak Associates fully exited Pfizer in Q3 2025, selling an estimated $10.3M.
  • Oak Associates's ten largest holdings make up 49% of its $1.64B portfolio in Q3 2025.
  • Oak Associates opened 8 new positions and closed 9 in Q3 2025.
  • Oak Associates's portfolio value rose 7% quarter-over-quarter to $1.64B.

Based on Oak Associates's 13F filing for Q3 2025, filed 12 Nov 2025.